5. Ивашкин B.T., Драпкина О.М., Маев И.В. и др. Распространенность неалкогольной жировой болезни печени у пациентов амбулаторно-поликлинической практики в Российской Федерации: результаты исследования DIREG 2, РЖГГК, 2015, 6, 31–41.
6. Диагностика и лечение неалкогольной жировой болезни печени. Под ред. академика РАН, проф. Ивашкина В.Т. — Методические рекомендации для врачей. — Российское общество по изучению печени. — М., 2015.
7. Bhatia L.S. et al. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? European Heart Journal. 2012. 33:1190–1200. / doi:10.1093/eurheartj/ehr453.
8. Chalasani N., Younossi Z., Lavine J.E. et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology, (2012). 55: 2005–2023.
9. Harrison’s Principles of Internal Medicine, 17th ed., New York: McGraw-Hill Medical Publishing Division.
10. Шерлок ILL, Дули Дж. Заболевания печени и желчных путей: практическое руководство / Пер. с англ. / Под ред. Апросиной З.Г., Мухина Н.А. — М.: Гэотар Медицина, 1999. — 864 с.
11. Musso G., Gambino R., Cassader M. Non-alcoholic fatty liver disease from pathogenesis to management: an update // Obesity Reviews. — 2010. — № 11(6). — P. 430–45.
12. McPherson S., Hardy T., Henderson E. et al. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management //J. Hepatol. 2015. Vol. 62. № 5. P. 1148–1155.
13. Musso G., Gambino R., Cassader M., Pagano G.F., (2011). Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 43: 617–649.
14. Benedict M., Zhang X.. Non-alcoholic fatty liver disease: An expanded review. World Journal of Hepatology. 2017;9(16):715–732. doi:10.4254/wjh.v9.il6.715.
15. Lazo M., Clark J. The epidemiology of nonalcoholic fatty liver disease: a global perspective // Semin Liver Dis. -2008.-№ 28(4). — P. 339–50.
16. Doycheva, Cui J., Nguyen P. et al. Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE. Alimentary Pharmacology & Therapeutics, January 2016, Volume 43, Issue 1, pages 83–95.
17. Lonardo A., Bellentani S., Argo C.K. et al. Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups. Dig Liver Dis. 2015; 47(12):997-1006. doi: 10.1016/j.dld.2015.08.004.
